TET2 Antibody
Référence ASC11778
Conditionnement : 100ug
Marque : Abcepta
TET2 Antibody
Application ![]()
| WB, E |
|---|---|
| Primary Accession | Q6N021 |
| Other Accession | NP_001120680, 187761317 |
| Reactivity | Human, Mouse |
| Host | Rabbit |
| Clonality | Polyclonal |
| Isotype | IgG |
| Calculated MW | Predicted: 220 kDa Observed: 220 kDa |
| Application Notes | TET2 antibody can be used for detection of TET2 by Western blot at 1 - 2 µg/ml. |
| Gene ID | 54790 |
|---|---|
| Target/Specificity | TET2; TET2 antibody is human and mouse reactive. At least two isoforms of TET2 are known to exist; this antibody will detect the larger isoforms. This antibody is predicted to not cross-react with TET1 and TET3. |
| Reconstitution & Storage | TET2 antibody can be stored at 4℃ for three months and -20℃, stable for up to one year. |
| Precautions | TET2 Antibody is for research use only and not for use in diagnostic or therapeutic procedures. |
For Research Use Only. Not For Use In Diagnostic Procedures.
| Name | TET2 |
|---|---|
| Synonyms | KIAA1546 |
| Function | Dioxygenase that catalyzes the conversion of the modified genomic base 5-methylcytosine (5mC) into 5-hydroxymethylcytosine (5hmC) and plays a key role in active DNA demethylation. Has a preference for 5-hydroxymethylcytosine in CpG motifs. Also mediates subsequent conversion of 5hmC into 5-formylcytosine (5fC), and conversion of 5fC to 5-carboxylcytosine (5caC). Conversion of 5mC into 5hmC, 5fC and 5caC probably constitutes the first step in cytosine demethylation. Methylation at the C5 position of cytosine bases is an epigenetic modification of the mammalian genome which plays an important role in transcriptional regulation. In addition to its role in DNA demethylation, also involved in the recruitment of the O-GlcNAc transferase OGT to CpG-rich transcription start sites of active genes, thereby promoting histone H2B GlcNAcylation by OGT. |
| Cellular Location | Nucleus. Chromosome. Note=Localization to chromatin depends upon monoubiquitination at Lys-1299. |
| Tissue Location | Broadly expressed. Highly expressed in hematopoietic cells; highest expression observed in granulocytes Expression is reduced in granulocytes from peripheral blood of patients affected by myelodysplastic syndromes. |



